Corrigendum: Gastroenterology (Gastroenterology (2010) 139(2) (586–597.e6), (S0016508510006633), (10.1053/j.gastro.2010.04.055));LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest

Gastroenterology

Volumn 139, Issue 2, 2010, Pages 632-

  Morton, Jennifer P ^a,b   Jamieson, Nigel B ^b,c   Karim, Saadia A ^a   Athineos, Dimitris ^a,b   Ridgway, Rachel A ^a   Nixon, Colin ^a   McKay, Colin J ^c   Carter, Ross ^c   Brunton, Valerie G ^d   Frame, Margaret C ^d   Ashworth, Alan ^e   Oien, Karin A ^b   Evans, T R Jeffry ^a,b   Sansom, Owen J ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Kras; LKb1; p21; Pancreatic Cancer

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA; K RAS PROTEIN; PROTEIN KINASE LKB1; PROTEIN P53; CDKN1A PROTEIN, HUMAN; CDKN1A PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; INSULIN PROMOTER FACTOR 1; KRAS2 PROTEIN, MOUSE; PROTEIN P21; PROTEIN SERINE THREONINE KINASE; STK11 PROTEIN, HUMAN; STK11 PROTEIN, MOUSE; TRANSACTIVATOR PROTEIN;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ASSESSMENT; COCARCINOGENESIS; CONTROLLED STUDY; DISEASE COURSE; DNA MODIFICATION; DOWN REGULATION; GENE EXPRESSION; GENE LOSS; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; IN VIVO STUDY; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; ANIMAL; CELL TRANSFORMATION; GENETICS; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; METABOLISM; MORTALITY; MOUSE MUTANT; PANCREAS TUMOR; PATHOLOGY; PHENOTYPE; PROMOTER REGION; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; TIME;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE PROGRESSION; GENES, TUMOR SUPPRESSOR; GENOTYPE; HAPLOTYPES; HETEROZYGOTE; HOMEODOMAIN PROTEINS; HOMOZYGOTE; HUMANS; MICE; MICE, KNOCKOUT; PANCREATIC NEOPLASMS; PHENOTYPE; PROGNOSIS; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS P21(RAS); RISK ASSESSMENT; TIME FACTORS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77955488036     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2024.05.020     Document Type: Erratum

References (38)

1. A. Jemal, R. Siegel, E. Ward, et al. Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66
2. S.F. Sener, A. Fremgen, H.R. Menck, and D.P. Winchester Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1999 1 7
3. R.H. Hruban, M. Goggins, J. Parsons, and S.E. Kern Progression model for pancreatic cancer Clin Cancer Res 6 2000 2969 2972
4. C. Almoguera, D. Shibata, K. Forrester, et al. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes Cell 53 1988 549 554
5. A. Hemminki, D. Markie, I. Tomlinson, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome Nature 391 1998 184 187
6. A. Hemminki, I. Tomlinson, D. Markie, et al. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis Nat Genet 15 1997 87 90
7. F.M. Giardiello, J.D. Brensinger, A.C. Tersmette, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome Gastroenterology 119 2000 1447 1453
8. H. Mehenni, N. Resta, J.G. Park, et al. Cancer risks in LKB1 germline mutation carriers Gut 55 2006 984 990
9. W. Lim, S. Olschwang, J.J. Keller, et al. Relative frequency and morphology of cancers in STK11 mutation carriers Gastroenterology 126 2004 1788 1794
10. S. Qanungo, S. Haldar, and A. Basu Restoration of silenced Peutz-Jeghers syndrome gene, LKB1, induces apoptosis in pancreatic carcinoma cells Neoplasia 5 2003 367 374
11. N. Sato, C. Rosty, M. Jansen, et al. STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas Am J Pathol 159 2001 2017 2022
12. A. Ylikorkala, D.J. Rossi, N. Korsisaari, et al. Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice Science 293 2001 1323 1326
13. N. Bardeesy, M. Sinha, A.F. Hezel, et al. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation Nature 419 2002 162 167
14. H. Miyoshi, M. Nakau, T.O. Ishikawa, et al. Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice Cancer Res 62 2002 2261 2266
15. K. Jishage, J. Nezu, Y. Kawase, et al. Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis Proc Natl Acad Sci U S A 99 2002 8903 8908
16. D.J. Rossi, A. Ylikorkala, N. Korsisaari, et al. Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis Proc Natl Acad Sci U S A 99 2002 12327 12332
17. R.J. Shaw, M. Kosmatka, N. Bardeesy, et al. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress Proc Natl Acad Sci U S A 101 2004 3329 3335
18. P. Karuman, O. Gozani, R.D. Odze, et al. The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death Mol Cell 7 2001 1307 1319
19. M. Tiainen, A. Ylikorkala, and T.P. Makela Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest Proc Natl Acad Sci U S A 96 1999 9248 9251
20. M. Tiainen, K. Vaahtomeri, A. Ylikorkala, and T.P. Makela Growth arrest by the LKB1 tumor suppressor: induction of p21(WAF1/CIP1) Hum Mol Genet 11 2002 1497 1504
21. P.Y. Zeng, and S.L. Berger LKB1 is recruited to the p21/WAF1 promoter by p53 to mediate transcriptional activation Cancer Res 66 2006 10701 10708
22. S.R. Hingorani, E.F. Petricoin, A. Maitra, et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse Cancer Cell 4 2003 437 450
23. G. Gu, J. Dubauskaite, and D.A. Melton Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors Development 129 2002 2447 2457
24. E.L. Jackson, K.P. Olive, D.A. Tuveson, et al. The differential effects of mutant p53 alleles on advanced murine lung cancer Cancer Res 65 2005 10280 10288
25. K. Sakamoto, A. McCarthy, D. Smith, et al. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction EMBO J 24 2005 1810 1820
26. C. Deng, P. Zhang, J.W. Harper, S.J. Elledge, and P. Leder Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control Cell 82 1995 675 684
27. A.F. Hezel, S. Gurumurthy, Z. Granot, et al. Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms Mol Cell Biol 28 2008 2414 2425
28. J. Nezu, A. Oku, and M. Shimane Loss of cytoplasmic retention ability of mutant LKB1 found in Peutz-Jeghers syndrome patients Biochem Biophys Res Commun 261 1999 750 755
29. M. Collado, J. Gil, A. Efeyan, et al. Tumour biology: senescence in premalignant tumours Nature 436 2005 642
30. A. Scarpa, P. Capelli, K. Mukai, et al. Pancreatic adenocarcinomas frequently show p53 gene mutations Am J Pathol 142 1993 1534 1543
31. B. Zheng, J.H. Jeong, J.M. Asara, et al. Oncogenic B-RAF negatively regulates the tumor suppressor LKB1 to promote melanoma cell proliferation Mol Cell 33 2009 237 247
32. H. Ji, M.R. Ramsey, D.N. Hayes, et al. LKB1 modulates lung cancer differentiation and metastasis Nature 448 2007 807 810
33. B.Y. Shorning, J. Zabkiewicz, A. McCarthy, et al. Lkb1 deficiency alters goblet and Paneth cell differentiation in the small intestine PLoS ONE 4 2009 e4264
34. M. Esteller, E. Avizienyte, P.G. Corn, et al. Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome Oncogene 19 2000 164 168
35. S. Prince, S. Carreira, K.W. Vance, A. Abrahams, and C.R. Goding Tbx2 directly represses the expression of the p21(WAF1) cyclin-dependent kinase inhibitor Cancer Res 64 2004 1669 1674
36. B. Viollet, F. Andreelli, S.B. Jorgensen, et al. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity J Clin Invest 111 2003 91 98
37. A. Wodarz, and I. Nathke Cell polarity in development and cancer Nat Cell Biol 9 2007 1016 1024
38. N. Moniaux, M. Andrianifahanana, R.E. Brand, and S.K. Batra Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy Br J Cancer 91 2004 1633 1638